Mergers and Acquisitions

Two Zeneca Defenses Nixed In $275M Chancery Drug Dispute

Zeneca Inc. on Friday lost two of 10 affirmative defenses claimed in a Chancery Court battle over $275 million in cancer drug trial "milestone" payments sought by a merger partner, with a Delaware vice chancellor saying the case nevertheless ...read more